DDAVP (desmopressin) for bleeding during heart surgery
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study tests whether a medicine called desmopressin (DDAVP) can reduce bleeding during heart surgery. It uses a special blood test (TEG6) to decide who gets the medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are scheduled for elective heart surgery with a heart-lung machine (cardiopulmonary bypass).
- You are able to understand and agree to the study.
- You do not have low sodium levels (hyponatremia).
- You are not allergic to desmopressin (DDAVP).
- You have not had a heart artery clot, stroke, mini-stroke, or deep vein clot recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two medications, tranexamic acid and desmopressin, to see if they can reduce bleeding during surgery in people with severe kidney disease or on dialysis. The results may help make surgery safer for you.
This trial is testing a drug called desmopressin to see if it can reduce the need for blood transfusions in patients at high risk of bleeding during heart surgery. If you qualify, you may be randomly assigned to receive the drug or a placebo (a dummy treatment) during surgery, and the study will monitor how much blood you need.
This trial tests if desmopressin can lower bleeding risk during a kidney transplant biopsy. It may help patients with reduced kidney function who need a biopsy.
This trial tests whether desmopressin can make kidney biopsy safer by reducing bleeding risk. It compares safety outcomes after a biopsy in people who meet specific blood, medication, and health criteria.
This study compares two ways of giving a medicine called tranexamic acid — as a pill or through an IV — to see which works better at reducing bleeding during heart bypass surgery. If you are having heart surgery without a heart-lung machine, this trial may help you recover with less bleeding.
This trial tests whether giving desmopressin (a drug that helps the body hold onto water) during surgery can prevent fluid and sodium balance problems in people having complex pituitary or sellar region tumor surgery. It’s designed for those at higher risk of these issues.
Hear when a new Intraoperative Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.